Determining the frequency of de novo germline mutations in DNA mismatch repair genes
- 2 June 2011
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 48 (8), 530-534
- https://doi.org/10.1136/jmedgenet-2011-100082
Abstract
Background Carriers of a germline mutation in a DNA mismatch repair (MMR) gene—that is, persons with Lynch syndrome—have substantially high risks of colorectal (CRC), endometrial, and several other cancers. The proportion of carriers who have de novo mutations (not inherited from either parent) is not known. This study reports a case series of de novo mutations in MMR genes and estimates the frequency of de novo mutation in MMR genes using the Colon Cancer Family Registry. Methods Screening for germline MLH1, MSH2, MSH6, and PMS2 mutations was performed for all incident CRC cases recruited from cancer registries (population based probands) displaying microsatellite instability (MSI) or loss of expression of MMR genes by immunohistochemistry (IHC) and probands with CRC in multi-case families recruited from clinics (clinic based probands), regardless of MSI or IHC status. All relatives of probands with a pathogenic mutation who donated a blood sample underwent testing for the mutation identified in the proband. Results Of 261 probands (202 clinic based, 59 population based) with MMR gene mutations for whom it was possible to determine the origin of the mutation, six (2.3%, 95% CI 0.9% to 5.0%) were confirmed as de novo, and the remaining 255 (97.7%, 95% CI 95.0% to 99.1%) were inherited. Of the de novo mutation carriers, three were clinic based probands (1.5%, 95% CI 0.3% to 4.5%) and three were population based probands (5.1%, 95% CI 1.2% to 14.5%). Two were in MLH1, three in MSH2, and one in MSH6. Conclusion De novo MMR gene mutations are uncommon causes of Lynch syndrome.Keywords
This publication has 28 references indexed in Scilit:
- The Search for Unaffected Individuals with Lynch Syndrome: Do the Ends Justify the Means?Cancer Prevention Research, 2011
- The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial diseaseGut, 2010
- Risks of Lynch Syndrome Cancers for MSH6 Mutation CarriersJNCI Journal of the National Cancer Institute, 2010
- Genetic Testing for Hereditary Colorectal CancerSurgical Oncology Clinics of North America, 2009
- Report on de-novo mutation in the MSH2 gene as a rare event in hereditary nonpolyposis colorectal cancerEuropean Journal of Gastroenterology & Hepatology, 2008
- The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 MutationsGastroenterology, 2008
- Prediction of Germline Mutations and Cancer Risk in the Lynch SyndromeJAMA, 2006
- Population carrier frequency of hMSH2 and hMLH1 mutationsBritish Journal of Cancer, 2000
- Recurrent germline mutation in MSH2 arises frequently de novoJournal of Medical Genetics, 2000
- Approximate Is Better than "Exact" for Interval Estimation of Binomial ProportionsThe American Statistician, 1998